ClinVar Miner

Submissions for variant NM_001291303.3(FAT4):c.9313A>G (p.Ser3105Gly) (rs764097811)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Broad Institute Rare Disease Group, Broad Institute RCV001004887 SCV001164376 uncertain significance Van Maldergem syndrome 2 2018-12-03 criteria provided, single submitter research The heterozygous p.Ser3103Gly variant in FAT4 was identified by our study in the compound heterozygous state, with another VUS, in one individual with Van Maldergem syndrome. The p.Ser3103Gly variant in FAT4 has not been previously reported in individuals with Van Maldergem syndrome and has been identified in 0.003249% (1/30778) of South Asian chromosomes, 0.002980% (1/33556) of Latino chromosomes, and 0.002708% (3/110802) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD,; dbSNP rs764097811). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. Computational prediction tools and conservation analyses suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Ser3103Gly variant is uncertain. ACMG/AMP Criteria applied: PM2, BP4 (Richards 2015).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.